Environmental bodies will be stripped of their powers to delay major infrastructure projects in a bid to “get Britain building” again.Read More

You might also be interested in reading Roivant Sciences targets brepocitinib expansion with new cutaneous sarcoidosis trial amid $5.2B cash position.